Explore comprehensive CDMO services offered by KBI Biopharma, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. KBI Biopharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Switzerland, U.S.A.
Description: KBI Biopharma is a global contract development and manufacturing organization (CDMO) that provides integrated services for drug development and manufacturing to pharmaceutical and biotechnology companies. It offers a wide range of services, including process development, analytical services, and clinical and commercial manufacturing for mammalian, microbial, and cell therapy programs. As a subsidiary of JSR Life Sciences, KBI focuses on accelerating drug development for its clients with expertise in areas like cell line development, bioprocess optimization, and large-scale manufacturing.